Clindamycin Palmitate

CHEMBL1201289 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

663.4 g/mol

LogP

10.1

Phase

4

An inactive form of the antibiotic clindamycin that is converted to its active parent compound after absorption. It is used to treat bacterial infections caused by certain anaerobic bacteria and gram-positive organisms, including skin and respiratory tract infections. This salt form is most commonly used in oral liquid preparations for easier dosing.

Peso Molecular

663,4000 g/mol

LogP

10,10

TPSA

134,00 Å²

Regra dos 5 de Lipinski

Reprovado

Áreas Terapêuticas

Endometriosis Pain Management Rheumatoid Arthritis Asthma Insomnia Obesity Lymphoma Hypertension Breast Cancer Chronic Pain Malaria Heart Failure Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC

InChI

InChI=1S/C34H63ClN2O6S/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-21-27(38)42-32-30(40)29(39)31(43-34(32)44-5)28(24(3)35)36-33(41)26-22-25(20-7-2)23-37(26)4/h24-26,28-32,34,39-40H,6-23H2,1-5H3,(H,36,41)/t24-,25+,26-,28+,29+,30-,31+,32+,34+/m0/s1

Molecular Formula

C34H63ClN2O6S

HBD / HBA

3 / 8

Ligações Rotacionáveis

23

Átomos Pesados

44

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

An inactive form of the antibiotic clindamycin that is converted to its active parent compound after absorption. It is used to treat bacterial infections caused by certain anaerobic bacteria and gram-positive organisms, including skin and respiratory tract infections. This salt form is most commonly used in oral liquid preparations for easier dosing.

Yes, Clindamycin Palmitate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201289. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 16052039. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Procura informações acessíveis para o paciente?

Clindamycin Palmitate no PillFYI

Estrutura

Dados Rápidos

Fórmula: C34H63ClN2O6S
Sinônimos: 3

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.